Trio Lifescience Private Limited

Pharmacopoeal  Name :

Teneligliptin 20 mg & Metformin 500 mg Tablets

Brand Name :

GLIPTON-M1 Tablets

Composition :

Each uncoated Bilayered Tablet contains :

Teneligliptin Hydrobromide Hydrate I.P.

Eq. to Teneligliptin     20 mg.

Metformin Hydrochloride   I.P.  500 mg.

(As Extended Release)

Excipients               Q.  S.

Colour : Ferric Oxide Yellow (In Teneligliptin Layer)

Therapeutic Uses :

• Teneligliptin increases Insulin Release & decreases Glycogen Levels in the circulation in a Glucose dependent Manner.
• Metformin improves Glucose Tolerance in Patients with Type-II Diabetes. It decreases hepatic glucose production, decreases intestinal absorption of Glucose & improves Insulin sensitivity.

Unique Features :

• Very useful in patients with Cardio-vascular diseases.
• Metformin intolerable patients.
• Elderly diabetic Patients.
• Type-II Diabetes

Packing Unit :

Box Pack of 10 x 15 Tablets Blister strips

Pharmacopoeal  Name :

Metformin 500 mg  & Glimepiride 2 mg  Tablets

Brand Name :

GLYCOPROT-G2 Tablets

Composition :

Each uncoated Bilayered Tablet contains :

Metformin Hydrochloride         I.P.   500 mg

(In Prolonged Release form)

Glimepiride     I.P.   2 mg.

Excipients          Q. S.

Colour : Sunset Yellow FCF

Therapeutic Uses :

• Metformin is the 1^st Line Anti Hyperglycamic most commonly prescribed agent in Type-II Diabetes Patients
• Metformin improves sensitivity & Corrects impaired Glucose Metabolism.
• Metformin decreases Level of Total Cholesterol & LDL Level, maintaining HDL Levels.
• Glimepiride improves peripheral glucose uptake & decreases endogenous Glucose Production
• Effective & well tolerated oral anti-hyperglycemic drug.
• Improves Insulin Resistance.

Unique Features :

• Type-II Diabetes Preferred  Treatment.
• Type-II Diabetes with or without Obesity.

Packing Unit :

Box Pack of 10 x 15 Tablets Blister strips

Pharmacopoeal  Name :

Metformin 500 mg  & Glimepiride 2 mg  Tablets

Brand Name :

GLYCOPROT-G2 Tablets

Composition :

Each uncoated Bilayered Tablet contains :

Metformin Hydrochloride         I.P.   500 mg

(In Prolonged Release form)

Glimepiride     I.P.   2 mg.

Excipients          Q. S.

Colour : Sunset Yellow FCF

Therapeutic Uses :

• Metformin is the 1^st Line Anti Hyperglycamic most commonly prescribed agent in Type-II Diabetes Patients
• Metformin improves sensitivity & Corrects impaired Glucose Metabolism.
• Metformin decreases Level of Total Cholesterol & LDL Level, maintaining HDL Levels.
• Glimepiride improves peripheral glucose uptake & decreases endogenous Glucose Production
• Effective & well tolerated oral anti-hyperglycemic drug.
• Improves Insulin Resistance.

Unique Features :

• Type-II Diabetes Preferred  Treatment.
• Type-II Diabetes with or without Obesity.

Packing Unit :

Box Pack of 10 x 15 Tablets Blister strips

Pharmacopoeal  Name :

Metformin 500 mg Sustained Release Tablets

Brand Name :

GLYCOPROT-500 SR Tablets

Composition :

Each uncoated Tablet  contains:

Metformin Hydrochloride    I.P.   500 mg.

(In Sustained Release form)

Excipients         Q.  S.  

Therapeutic Uses :

• Metformin is the 1^st Line Anti Hyperglycamic most commonly prescribed agent in Type-II Diabetes Patients
• Metformin improves sensitivity & Corrects impaired Glucose Metabolism.
• Metformin decreases Level of Total Cholesterol & LDL Level, maintaining HDL Levels.

Unique Features :

• Type-II Diabetes 1^st Line Treatment.
• Adult Monotherapy for Type-II Diabetes.
• Obese Patients of Type-II Diabetes

Packing Unit :

Box Pack of 10 x 15 Tablets Blister strips